Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dexcom (DXCM) Interest & Investment Income (2016 - 2019)

Dexcom has reported Interest & Investment Income over the past 6 years, most recently at $6.9 million for Q1 2019.

  • Quarterly Interest & Investment Income rose 68.29% to $6.9 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Mar 2019, down 26.42% year-over-year, with the annual reading at $2.4 million for FY2018, 64.18% down from the prior year.
  • Interest & Investment Income was $6.9 million for Q1 2019 at Dexcom, up from -$3.8 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $6.9 million in Q1 2019 and troughed at -$3.8 million in Q4 2018.
  • The 4-year median for Interest & Investment Income is $500000.0 (2017), against an average of $1.4 million.
  • The largest YoY upside for Interest & Investment Income was 1950.0% in 2018 against a maximum downside of 179.17% in 2018.
  • A 4-year view of Interest & Investment Income shows it stood at -$600000.0 in 2016, then skyrocketed by 900.0% to $4.8 million in 2017, then crashed by 179.17% to -$3.8 million in 2018, then skyrocketed by 281.58% to $6.9 million in 2019.
  • Per Business Quant, the three most recent readings for DXCM's Interest & Investment Income are $6.9 million (Q1 2019), -$3.8 million (Q4 2018), and $2.5 million (Q3 2018).